Boldrin, Mark N.
4 papers on CoChat
Most cited papers
- Verified · note
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 1,915
- Verified
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients.
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M., Golay, A., Koppeschaar, H. P., & Krempf, M. (1998) · The Lancet
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 1,237
- Verified
Effect of Orlistat on Weight and Body Composition in Obese Adolescents: A Randomized Controlled Trial
Chanoine, J.-P., Hampl, S., Jensen, C., Boldrin, M., & Hauptman, J. (2005) · JAMA
Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet
Cited by 624
- Verified
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine
Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes
Cited by 358
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free